MedPath

IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing

Not Applicable
Completed
Conditions
Infertility
Registration Number
NCT02026193
Lead Sponsor
Rambam Health Care Campus
Brief Summary

The chances to achieve pregnancy after retrieving \>15 oocytes are not good, probably because of bad effect on the endometrium (uterine inner lining). Therefore, in most such cases the investigators prefer to freeze all embryos, and transfer in a thaw cycle. With the introduction of oocyte vitrification (very fast cooling) technology, a new option emerged: to freeze un-fertilized eggs, to be fertilized and used later in a thaw cycle.

The purpose of this study is to compare the outcome of these two approaches.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
11
Inclusion Criteria
  • IVF patients
  • ovulation trigger with Decapeptyl 0.2 mg because of ovarian hyper-response: E2 on trigger day .12,000 pmol/l and/or >15 oocytes.
  • Normal uterus
Exclusion Criteria
  • <20% fertilization rate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Fetal Heart Activity 1 Month Post Embryo Transfer1 month after embryo transfer

Fetal heart activity as demonsrated by vaginal ultrasound 1 month post embryo transfer

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IVF Unit, Rambam medical Center

🇮🇱

Haifa, Israel

IVF Unit, Rambam medical Center
🇮🇱Haifa, Israel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.